Overview

  • Product nameURB754
  • Description
    Monoacylglycerol lipase inhibitor
  • Biological descriptionReported potent and non-competitive monoacylglycerol lipase (MAGL) inhibitor (IC50 = 200 nM). Inhibits FAAH (IC50 = 32 µM) and binds weakly to the rat CB1 receptor (IC50 = 3.8 µM). Shows vasodilatory activity.
  • Purity> 98%

Properties

    References for URB754 (ab120927)

    This product has been referenced in:
    • Hillard CJ  et al. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. Br J Pharmacol 152:691-8 (2007). Read more (PubMed: 17891162) »
    • Saario SM  et al. URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain. Chem Biol 13:811-4 (2006). Read more (PubMed: 16931330) »
    • Makara JK  et al. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci 8:1139-41 (2005). Read more (PubMed: 16116451) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120927.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"